Australia's SDI hits over 2-mth high on FDA nod for product in U.S.

SDI

21/11/2022 04:33

** Shares of SDI Ltd  SDI.AX  rise as much as 4.7% to A$0.9,
highest since Sept. 1 
    ** Dental technology co receives U.S. Food and Drug
Administration approval for co's new amalgam replacement product
called ‘Stela’
    ** Says product's formal launch in the U.S. anticipated in
first quarter of FY24
    ** More than 105,590 shares trade hand compared to 30-day
average trading volume of 17,990 shares  
    ** Shares of co are down 15.3% YTD as of last close 
 (Reporting by John Biju in Bengaluru)
 ((John.Biju@thomsonreuters.com;))